Suven Pharma

SUVENPHAR30 Apr 2024

Pharmaceuticals

₹

+13.60 (+2.11%)

Lowest Today

Highest Today

Prev. Close

Today’s Open

52 Week High

52 Week Low

BUY

SELL

To Invest in Suven Pharma

Suven Pharma

Pharmaceuticals

SUVENPHAR30 Apr 2024

₹

+13.60 (+2.11%)

OverviewFundamentals

Corporate action

Peer comparison

Income Sheet

Balance sheet

Cash flow

Share holding

About Us

Corporate Action

These are actions taken by a company that impact the shareholders value directly. It is an event that brings material changes to a company and affects its stakeholders.

All

Dividends

Bonus

Splits

Others

Ex-Date	Type	Description	Record Date	Ratio
02-Sep-2022	D	With reference to the above subject, the Board of Directors of the company, at its meeting held today i.e. September 02, 2022, approved the following matters. Interim Dividend a) The Board has declared an Interim Dividend of Rs.1.00 per equity share (100% of face value of Rs.1.00 each) and special dividend of Rs. 5.00 per equity share (500% of face value of Rs.1.00), totaling to Rs. 6.00 per equity share (600% of face value of Rs. 1.00 each) for the financial year 2022-23. b) The Board has approved the Record Date i.e., September 12, 2022 notified earlier by the Company for the purpose of payment of dividend to the eligible shareholders. c) The above said dividend will be paid on and from September 20, 2022. The Board Meeting commenced at 12:30 P.M. and concluded at 1:20 P.M.	09-Sep-2022
02-Sep-2022	D	With reference to the above subject, the Board of Directors of the company, at its meeting held today i.e. September 02, 2022, approved the following matters. Interim Dividend a) The Board has declared an Interim Dividend of Rs.1.00 per equity share (100% of face value of Rs.1.00 each) and special dividend of Rs. 5.00 per equity share (500% of face value of Rs.1.00), totaling to Rs. 6.00 per equity share (600% of face value of Rs. 1.00 each) for the financial year 2022-23. b) The Board has approved the Record Date i.e., September 12, 2022 notified earlier by the Company for the purpose of payment of dividend to the eligible shareholders. c) The above said dividend will be paid on and from September 20, 2022. The Board Meeting commenced at 12:30 P.M. and concluded at 1:20 P.M.	09-Sep-2022
09-May-2022	D	With reference to the above subject, we wish to inform you that the Board of Directors of the company, at its meeting held today i.e. May 9, 2022, approved the following along with other business matters. 2nd Interim Dividend a) The Board has declared 2nd Interim Dividend of Rs.1.00 per equity share (100% of Face value of Rs.1.00 each) and one-time special dividend of Rs. 1.00 per equity share (100% of Face value of Rs.1.00), totaling to Rs. 2.00 per equity share (200% of Face value of Rs. 1.00 each) for the financial year 2021-22. b) The Board has approved the Record Date i.e., 17th May, 2022 notified earlier by the Company for the purpose of payment of dividend to the eligible shareholders. c) The above said dividend will be	13-May-2022
09-May-2022	D	With reference to the above subject, we wish to inform you that the Board of Directors of the company, at its meeting held today i.e. May 9, 2022, approved the following along with other business matters. 2nd Interim Dividend a) The Board has declared 2nd Interim Dividend of Rs.1.00 per equity share (100% of Face value of Rs.1.00 each) and one-time special dividend of Rs. 1.00 per equity share (100% of Face value of Rs.1.00), totaling to Rs. 2.00 per equity share (200% of Face value of Rs. 1.00 each) for the financial year 2021-22. b) The Board has approved the Record Date i.e., 17th May, 2022 notified earlier by the Company for the purpose of payment of dividend to the eligible shareholders. c) The above said dividend will be	13-May-2022
08-Feb-2022	D	Suven Pharmaceuticals Ltd has informed BSE that the Board of Directors of the Company at its meeting held on February 08, 2022, inter alia, has declared an interim Dividend of Rs.1.00 per equity share (100% of Face value of Rs.1.00 each) and one-time special dividend of Rs. 2.00 per equity share (200% of Face value of Rs.1.00), totaling to Rs. 3.00 per equity share (300% of Face value of Rs. 3.00 each) for the financial year 2021-22. The above said dividend will be paid on and from February 22, 2022.	15-Feb-2022
08-Feb-2022	D	Suven Pharmaceuticals Ltd has informed BSE that the Board of Directors of the Company at its meeting held on February 08, 2022, inter alia, has declared an interim Dividend of Rs.1.00 per equity share (100% of Face value of Rs.1.00 each) and one-time special dividend of Rs. 2.00 per equity share (200% of Face value of Rs.1.00), totaling to Rs. 3.00 per equity share (300% of Face value of Rs. 3.00 each) for the financial year 2021-22. The above said dividend will be paid on and from February 22, 2022.	15-Feb-2022
08-Jun-2021	D	Suven Pharmaceuticals Ltd has informed BSE that the Board of Directors of the Company at its meeting held on June 08, 2021, inter alia, has recommended a final dividend of Rs. 1.00 per equity share of face value of Rs 1/- each for the year 2020-2021.	13-Aug-2021
10-Feb-2021	D	With reference to the above subject, the Board of Directors of the company, at its meeting held today i.e. February 10, 2021, approved the following along with other business matters. 2. Interim Dividend a) The Board has also declared an interim dividend of Rs. 1.00 per equity share of face value of Rs 1/- each for the year 2020-2021. b) The Board approved the Record Date i.e., 18th February, 2021 notified by the Company for the purpose of payment of interim dividend to the eligible shareholders. c) The above said dividend will be paid on or before 11th March, 2021	17-Feb-2021
18-Sep-2020	B	1:1 Bonus Issue of Equity Shares Trading Members of the Exchange are hereby informed that, Suven Pharmaceuticals Ltd. has fixed the record date for the purpose of Bonus Issue. The transactions in the equity shares of the Bank would be on an ex-bonus basis with effect from the under mentioned date. DEMATERIALISED SECURITIES - ROLLING SETTLEMENT SEGMENT COMPANY NAME & CODE Suven Pharmaceuticals Ltd. (543064) RECORD DATE 28.09.2020 PURPOSE Issue of 1 (One) Bonus equity share of Rs.1/- each for every 1 (One) existing equity share of Rs.1/- each held. Ex-Bonus basis from Date & Sett. No. 25/09/2020 DR-124/2019-2020 Trading Members of the Exchange are requested to take of it. (As Per BSE Notice Dated on 21.09.2020)	28-Sep-2020	1:1
05-Mar-2024	BC	DSP Trustee Pvt Ltd & PACs	01-Mar-2024
29-Feb-2024	BC	Outcome of the Board Meeting Outcome of the Board Meeting started at 17.30 and ended at 18.30	29-Feb-2024
12-Jan-2024	BC	Notice of Postal Ballot SUVEN PHARMACEUTICALS LIMITED has informed BSE about Notice of Shareholders Meeting for Postal Ballot. Disclosure of Voting Results - Postal Ballot (As Per BSE Announ	13-Feb-2024
29-Jan-2024	BC	Suven Pharmaceuticals Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 05/02/2024 inter alia to consider and approve With reference to above subject pursu	05-Feb-2024
21-Dec-2023	BC	Pursunat to the recommendations of NRC and approval of Audit Committee, the Board has considered and approved the appointment of Mr. Himanshu Agarwal as the Chief Financial Officer and Key Managerial	02-Jan-2024

Announcement Date02-Sep-2022

Ex Dividend Date09-Sep-2022

Dividend(%)100

Announcement Date02-Sep-2022

Ex Dividend Date09-Sep-2022

Dividend(%)500

Announcement Date09-May-2022

Ex Dividend Date13-May-2022

Dividend(%)100

Announcement Date09-May-2022

Ex Dividend Date13-May-2022

Dividend(%)100

Announcement Date08-Feb-2022

Ex Dividend Date15-Feb-2022

Dividend(%)100

Announcement Date08-Feb-2022

Ex Dividend Date15-Feb-2022

Dividend(%)200

Announcement Date08-Jun-2021

Ex Dividend Date13-Aug-2021

Dividend(%)100

Announcement Date10-Feb-2021

Ex Dividend Date17-Feb-2021

Dividend(%)100

No Rights has been declared by SUVENPHAR

Book Closure

Record Date	Split Date	Purpose
01-Mar-2024	-	DSP Trustee Pvt Ltd & PACs
29-Feb-2024	-	Outcome of the Board Meeting Outcome of the Board Meeting started at 17.30 and ended at 18.30
13-Feb-2024	01 Jan'1900	Notice of Postal Ballot SUVEN PHARMACEUTICALS LIMITED has informed BSE about Notice of Shareholders Meeting for Postal Ballot. Disclosure of Voting Results - Postal Ballot (As Per BSE Announ
05-Feb-2024	-	Suven Pharmaceuticals Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 05/02/2024 inter alia to consider and approve With reference to above subject pursu
02-Jan-2024	-	Pursunat to the recommendations of NRC and approval of Audit Committee, the Board has considered and approved the appointment of Mr. Himanshu Agarwal as the Chief Financial Officer and Key Managerial

Peer Comparison

These are actions taken by a company that impact the shareholders value directly. It is an event that brings material changes to a company and affects its stakeholders.

Scrip Name	Price	Daily Change	M.Cap (Cr)	1 Year Returns %	P/E (TTM)	PB Ratio
Suven Pharmaceuticals Ltd ₹658.05(+13.60/2.11%)	658.05	+13.60	16,751.65	40.09	43.90	8.60
Astrazeneca Pharma India Ltd ₹5,341.25(-214.85/-3.87%)	5,341.25	-214.85	13,353.13	68.03	83.72	20.39
Bliss GVS Pharma Ltd ₹123.70(-0.75/-0.60%)	123.70	-0.75	1,295.03	60.30	18.97	1.32
Cipla Ltd ₹1,401.20(-6.35/-0.45%)	1,401.20	-6.35	113,132.18	52.94	34.40	4.37
Abbott India Ltd ₹26,415.75(+138.15/0.53%)	26,415.75	+138.15	56,133.47	18.05	49.00	18.06
Amrutanjan Health Care Ltd ₹697.95(-11.45/-1.61%)	697.95	-11.45	2,017.82	15.18	45.86	7.70

Income Sheet

These are actions taken by a company that impact the shareholders value directly. It is an event that brings material changes to a company and affects its stakeholders.

Standalone

Consolidated

Column	Dec 23	Sep 23	Jun 23	Mar 23	Dec 22	Sep 22
Gross Sales	212.83	224.62	344.03	364.39	348.49	278.40
Excise Duty	0.00	0.00	0.00	0.00	0.00	0.00
Net Sales	212.83	224.62	344.03	364.39	348.49	278.40
Other Operating Income	0.00	0.00	0.00	0.00	0.00	0.00
Other Income	13.97	14.20	10.06	10.75	12.51	10.39
Total Income	226.79	238.82	354.08	375.14	361.00	288.79
Total Expenditure	144.69	127.27	174.14	189.76	201.42	171.76
PBIDT	82.10	111.55	179.94	185.38	159.58	117.03
Interest	1.27	0.50	1.15	2.29	1.38	0.29
PBDT	80.84	111.05	178.79	183.09	158.20	116.74
Depreciation	11.33	10.48	11.15	10.63	10.91	10.76
Tax	13.07	24.29	41.31	40.80	37.15	25.62
Deferred Tax	4.06	1.55	2.04	1.51	0.67	1.44
Reported Profit After Tax	52.36	74.73	124.29	130.16	109.47	78.92
Extra-ordinary Items	0.00	0.00	0.00	0.00	0.00	0.00
Adjusted Profit After Extra-ordinary item	52.36	74.73	124.29	130.16	109.47	78.92

EPS (Unit Curr.)	2.06	2.94	4.88	5.11	4.30	3.10
EPS (Adj) (Unit Curr.)	2.06	2.94	4.88	5.11	4.30	3.10
Calculated EPS (Unit Curr.)	2.06	2.94	4.88	5.11	4.30	3.10
Calculated EPS (Adj) (Unit Curr.)	2.06	2.94	4.88	5.11	4.30	3.10
Calculated EPS (Ann.) (Unit Curr.)	8.23	11.74	19.53	20.45	17.20	12.40
Calculated EPS (Adj) (Ann.) (Unit Curr.)	8.23	11.74	19.53	20.45	17.20	12.40
Book Value (Unit Curr.)	0.00	0.00	0.00	0.00	0.00	0.00
Dividend (%)	0.00	0.00	0.00	0.00	0.00	600.00
Equity	25.46	25.46	25.46	25.46	25.46	25.46
Reserve & Surplus	0.00	0.00	0.00	0.00	0.00	0.00
Face Value	1.00	1.00	1.00	1.00	1.00	1.00

Public Shareholding (No. Of Shares)	0.00	0.00	0.00	0.00	0.00	0.00
Public Shareholding (% in Equity)	0.00	0.00	0.00	0.00	0.00	0.00

Pledged/Encumbered - No. of Shares	0.00	0.00	0.00	0.00	0.00	0.00
Pledged/Encumbered - % in Total Promoters Holding	0.00	0.00	0.00	0.00	0.00	0.00
Pledged/Encumbered - % in Total Equity	0.00	0.00	0.00	0.00	0.00	0.00

Non Encumbered - No. of Shares	0.00	0.00	0.00	0.00	0.00	0.00
Non Encumbered - % in Total Promoters Holding	0.00	0.00	0.00	0.00	0.00	0.00
Non Encumbered - % in Total Equity	0.00	0.00	0.00	0.00	0.00	0.00

PBIDTM(%)	38.58	49.66	52.30	50.87	45.79	42.04
PBDTM(%)	37.98	49.44	51.97	50.25	45.40	41.93
PATM(%)	24.60	33.27	36.13	35.72	31.41	28.35

Column	Dec 23	Sep 23	Jun 23	Mar 23	Dec 22	Sep 22
Gross Sales	219.82	231.05	347.55	369.36	353.77	278.40
Excise Duty	0.00	0.00	0.00	0.00	0.00	0.00
Net Sales	219.82	231.05	347.55	369.36	353.77	278.40
Other Operating Income	0.00	0.00	0.00	0.00	0.00	0.00
Other Income	14.34	19.84	10.67	11.40	13.01	10.92
Total Income	234.16	250.90	358.22	380.76	366.78	289.32
Total Expenditure	154.68	133.09	180.58	200.28	207.08	178.52
PBIDT	79.49	117.80	177.63	180.48	159.71	110.80
Interest	1.27	0.50	1.15	2.31	1.38	0.29
PBDT	78.22	117.30	176.48	178.17	158.32	110.51
Depreciation	12.75	11.89	12.54	11.96	12.24	12.03
Minority Interest Before NP	0.00	0.00	0.00	0.00	0.00	0.00
Tax	14.65	24.29	41.31	40.73	37.70	24.98
Deferred Tax	4.06	1.55	2.04	1.51	0.67	1.44
Reported Profit After Tax	46.75	79.56	120.59	123.97	107.72	72.06
Minority Interest After NP	0.00	0.00	0.00	0.00	0.00	0.00
Net Profit after Minority Interest	46.75	79.56	120.59	123.97	107.72	72.06

Extra-ordinary Items	0.00	0.00	0.00	0.00	0.00	0.00
Adjusted Profit After Extra-ordinary item	46.75	79.56	120.59	123.97	107.72	72.06

EPS (Unit Curr.)	1.84	3.13	4.74	4.87	4.23	2.83
Book Value (Unit Curr.)	0.00	0.00	0.00	0.00	0.00	0.00
Dividend (%)	0.00	0.00	0.00	0.00	0.00	600.00
Equity	25.46	25.46	25.46	25.46	25.46	25.46

Public Shareholding (Number)	0.00	0.00	0.00	0.00	0.00	0.00
Public Shareholding (%)	0.00	0.00	0.00	0.00	0.00	0.00

Pledged/Encumbered - No. of Shares	0.00	0.00	0.00	0.00	0.00	0.00
Pledged/Encumbered - % in Total Promoters Holding	0.00	0.00	0.00	0.00	0.00	0.00
Pledged/Encumbered - % in Total Equity	0.00	0.00	0.00	0.00	0.00	0.00

Non Encumbered - No. of Shares	0.00	0.00	0.00	0.00	0.00	0.00
Non Encumbered - % in Total Promoters Holding	0.00	0.00	0.00	0.00	0.00	0.00
Non Encumbered - % in Total Equity	0.00	0.00	0.00	0.00	0.00	0.00

PBIDTM(%)	36.16	50.98	51.11	48.86	45.15	39.80
PBDTM(%)	35.58	50.77	50.78	48.24	44.75	39.69
PATM(%)	21.27	34.43	34.70	33.56	30.45	25.88

Balance Sheet

These are actions taken by a company that impact the shareholders value directly. It is an event that brings material changes to a company and affects its stakeholders.

Standalone

Consolidated

Cash Flow

These are actions taken by a company that impact the shareholders value directly. It is an event that brings material changes to a company and affects its stakeholders.

PARTICULARS	Mar 2023	Mar 2022	Mar 2021	Mar 2020	Mar 2019
Cash and Cash Equivalents at Beginning of the year	30.21	7.09	11.58	10.90	0.00
Net Cash from Operating Activities	484.17	269.89	328.84	358.75	50.40
Net Cash Used In Investing Activities	-235.57	-90.29	-257.66	-366.65	-65.48
Net Cash Used In Financing Activities	-235.79	-156.48	-75.66	8.57	25.98
Net Inc./Dec In Cash And Cash Equivalents	12.81	23.12	-4.49	0.67	10.90
Cash And Cash Equivalents At End Of The Year	43.02	30.21	7.09	11.58	10.90

Share Holding

These are actions taken by a company that impact the shareholders value directly. It is an event that brings material changes to a company and affects its stakeholders.

Promoter Shareholding

50.10%

FII Shareholding

9.54%

DII Shareholding

17.25%

Public Shareholding

23.10%

**Promoter pledged shareholding 50.10%

About Suven Pharmaceuticals Ltd

Suven Pharmaceuticals Ltd is in the Pharmaceuticals sector, having a market capitalization of Rs. 16751.65 crores. It has reported a sales of Rs. 212.83 crores and a net profit of Rs. 52.36 crores for the quarter ended December 2018. The company management includes Annaswamy Vaidheesh, Hanumantha Rao Kokkonda,Shweta Jalan,U B Pravin Rao,Annaswamy Vaidheesh,Venkatanaga Kali Vara Prasad Raju Vetukuri,Pankaj Patwari,Matangi Gowrishankar,Vinod Rao,K G Ananthakrishnan (Suven Pharmaceuticals Ltd) among others.

Chairman

Annaswamy Vaidheesh

Registered office

8-2-334 SDE Serene Chambers,3 Floor Avenue 7 Road No 5,Hyderabad,Telangana,500034

FAX :91-40-23541152

Background

Incorporation Year2018

Face Value₹1

Market Lot1

How to buy Suven Pharma shares on nse?

To buy Suven Pharma shares in Motilal Oswal, you just need to open a demat account and get your KYC documents verified

What is the Suven Pharma share price today?

The Suven Pharma shares price on nse is Rs.658.05 today.

What is the market cap of Suven Pharma shares on BSE ?

The company has a market capitalization of Rs.16751.65Cr

What is the PE & PB ratio of Suven Pharma shares ?

PE is 43.9 and PB is 8.6

What is the 52 Week High and Low of Suven Pharma shares?

Suven Pharma stock price high: Rs.767 Suven Pharma stock price low: Rs.427.05